Literature DB >> 6505777

Escherichia vulneris: isolation and treatment.

K R Dye, L Dall, J Yuhas, J L Brockert.   

Abstract

We have described two cases of Escherichia vulneris wound infections resistant to ampicillin given orally, but susceptible to higher blood levels obtainable by parenchymal administration.

Entities:  

Mesh：

Year:  1984        PMID： 6505777     DOI： 10.1097/00007611-198412000-00040

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  2 in total

1.  In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.

Authors:  P Hohl; J Lüthy-Hottenstein; J Zollinger-Iten; M Altwegg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Colonization of human wounds by Escherichia vulneris and Escherichia hermannii.

Authors:  F D Pien; S Shrum; J M Swenson; B C Hill; C Thornsberry; J J Farmer
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.